BioNTech’s Bet on BNT323 Intensifies as Restructuring and Pipeline Data Pave Way for Regulatory Milestone
The next few months will decide whether BioNTech can turn its sprawling oncology pipeline into a revenue-generating reality. With a...
The next few months will decide whether BioNTech can turn its sprawling oncology pipeline into a revenue-generating reality. With a...
ServiceNow investors have had whiplash. After a stunning 9.24% surge on June 1 that lifted the stock to $135.86, the...
Nokia’s stock closed at €12.76 on Friday, down 2.67% — a modest retreat after a staggering 129% year-to-date surge that...
The week before the industry’s biggest hardware showcase in Taipei, Jensen Huang’s schedule read like a diplomatic ledger. On May...
The defence contractor BAE Systems has found itself at the centre of a perfect storm of positive forces, with shares...
The analyst community has piled into Marvell Technology with a flurry of upgraded price targets, led by HSBC's new Street-high...
A Ukrainian court hearing this week at the Pecherskyi District Court in Kyiv has added a fresh dimension to Ferrexpo’s...
The numbers are staggering. A 38% revenue surge to $10.25 billion. Data-center sales climbing 57% to $5.8 billion. A quarterly...
Barclays has more than quadrupled its price target on Micron in the space of six months, from $275 in December...
The proposed dual listing of KNDS in Frankfurt and Paris now turns on a single document: a signed audit opinion...
StocksToday.com is your one-stop destination for the latest stock news and analysis. We provide in-depth coverage of the stock market, including market news, company news, sector news, IPO news, investment strategies, personal finance, international markets, and more.
© 2023 StocksToday.com